HOPO Therapeutics

HOPO Therapeutics is a clinical-stage pharmaceutical company dedicated to pioneering innovative treatments and solutions in the realm of heavy metal poisoning and directed radioisotope delivery. Leveraging advanced research and cutting-edge technology licensed from Lawrence Berkeley National Laboratory, HOPO Therapeutics is committed to addressing the harmful effects of heavy metal contamination and harnessing the power of metals in medicine to enhance human health worldwide.

Located in the San Francisco Bay Area, HOPO Therapeutics focuses on safeguarding global populations from the dangers of heavy metal exposure. The company’s mission is driven by a commitment to improving health security and promoting global environmental health through advanced therapeutic interventions. HOPO Therapeutics is dedicated to developing solutions that address critical health challenges and improve the lives of individuals and communities around the world.

HOPO Therapeutics continues to expand its research and development efforts, aiming to provide innovative solutions for heavy metal toxicity and oncology. HOPO Therapeutics is poised to make significant contributions to the field of biotechnology and medicine. To the manager of HOPO Therapeutics, we invite you to create a customized and exclusive company showcase and product listing on our platform to further amplify your reach and impact.